Clinical Trials in Houston

Showing 6561-6580 of 17,885 trials

Trial of NanoPac® in Subjects With Locally Advanced Pancreatic Adenocarcinoma

NCT03077685

Open-label, dose-escalating, Phase IIa trial of NanoPac® to treat subjects with locally advanced pancreatic adenocarcinoma via direct intratumoral injection.

Locally Advanced Pancreatic Adenocarcinoma

NanOlogy, LLC54 participantsStarted Dec 2017

Los Angeles, California, United States • Fort Wayne, Indiana, United States • El Paso, Texas, United States +1 more locations

TERMINATEDPhase 3< 1 mile

A Study to Find Out if Selexipag is Effective and Safe in Patients With Chronic Thromboembolic Pulmonary Hypertension When the Disease is Inoperable or Persistent/Recurrent After Surgery and/or Interventional Treatment

NCT03689244

Selexipag is available in many countries for the treatment of pulmonary arterial hypertension (PAH). Due to the similarities between PAH and chronic thromboembolic pulmonary hypertension (CTEPH) and the observed efficacy of other PAH medicines in CTEPH, it is believed that selexipag could benefit to patients with CTEPH. This study aims to assess the efficacy and safety of selexipag in participants with inoperable or persistent/recurrent CTEPH.

Chronic Thromboembolic Pulmonary Hypertension

Actelion128 participantsStarted Jan 2019

La Jolla, California, United States • Los Angeles, California, United States • Aurora, Colorado, United States +159 more locations

Trial of NanoPac® in Subjects With Locally Advanced Pancreatic Adenocarcinoma

A Study to Find Out if Selexipag is Effective and Safe in Patients With Chronic Thromboembolic Pulmonary Hypertension When the Disease is Inoperable or Persistent/Recurrent After Surgery and/or Interventional Treatment

Find Trials by Condition in Houston

Phase 3 Study of Toripalimab Alone or in Combination With Tifcemalimab as Consolidation Therapy in Patients With Limited-stage Small Cell Lung Cancer (LS-SCLC)

Safety and Efficacy of Tipifarnib in Head and Neck Cancer With HRAS Mutations and Impact of HRAS on Response to Therapy

Study of the Safety and Efficacy of LHC165 Single Agent and in Combination With PDR001 in Patients With Advanced Malignancies

Comparison of Operating Room Time Length With the Use of Virtual Surgical Planning Versus Conventional Treatment of Mandible Fractures

Open-Label Study of Oral Treprostinil in Digital Ulcers

A Study of NOX66 and External Beam Radiotherapy in Patients With Metastatic Castration-resistant Prostate Cancer and Other Solid Tumors

Open Label Study of KRN23 on Osteomalacia in Adults With X-linked Hypophosphatemia (XLH)

An Extension Study of KRN23 in Adults With X-Linked Hypophosphatemia

A Study of TEPEZZA® Treatment in Participants With Thyroid Eye Disease

Study to Demonstrate the Efficacy, Safety and Tolerability of an Intravenous Regimen of Secukinumab Compared to Placebo in Subjects With Active axSpA

Proof of Concept Study of Rilzabrutinib in Adult Patients With Moderate-to-severe Atopic Dermatitis

Multiple Dose Safety and Efficacy of LKA651 in Patients With Diabetic Macular Edema

Hepatic Impairment Study for Lorlatinib in Cancer Patients

Study of Efficacy and Safety of CSJ117 in Patients With Severe Uncontrolled Asthma

Phase II Open Label Trial to Determine Safety & Efficacy of Tisagenlecleucel in Pediatric Non-Hodgkin Lymphoma Patients

Treatment of Tendinosis Using the TenJet Hydroresection System

Expanded Access Protocol of Teprotumumab (HZN-001) for Patients With Active Thyroid Eye Disease

Study of Efficacy and Safety of Ligelizumab in Adolescents and Adults With Chronic Inducible Urticaria Who Remain Symptomatic Despite Treatment With H1- Antihistamines